Mesothelioma News
MVP Does Not Provide Benefit in Mesothelioma Patients (May 21, 2008)MVP Does Not Provide Benefit in Mesothelioma Patients The chemotherapy agent Navelbine® (vinorelbine) may improve outcomes for patients with malignant pleural mesothelioma. However, the combination chemotherapy regimen referred to as MVP (mitoxantrone,... Continue Reading
Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (February 8, 2008)Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated and invasive standard procedures. These findings were... Continue Reading
Malignant Pleural Mesothelioma Updates (November 7, 2007)Malignant Pleural Mesothelioma Updates: Highlights from the 12th World Conference on Lung Cancer Introduction Malignant pleural mesothelioma (MPM) is a tumor that arises from the surfaces of the pleural and peritoneal cavities, the pericardium, or the... Continue Reading
Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma (June 26, 2007)Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma According to results recently presented at the 2007 annual meeting of the American Society of Clinical Oncology, the chemotherapy combination consisting of Alimta® (pemetrexed) plus... Continue Reading
Alimta® Alone or with Platinol® Benefits Patients with Recurrent Mesothelioma (August 3, 2006)Alimta® Alone or with Platinol® Benefits Patients with Recurrent Mesothelioma According to results recently published in the Journal of Thoracic Oncology, treatment with the chemotherapy agent Alimta® (pemetrexed) with or without the chemotherapy agent... Continue Reading
ONCONASE® Improves Survival in Inoperable Mesothelioma (May 10, 2006)ONCONASE® Improves Survival in Inoperable Mesothelioma According to a press release from Alfacell Corporation, the addition of ONCONASE® (ranpirnase) to Adriamycin® (doxorubicin) improves survival over doxorubicin alone in patients with inoperable... Continue Reading
Sequential Chemotherapy for Pleural Mesothelioma Promising (April 12, 2006)Sequential Chemotherapy for Pleural Mesothelioma Promising According to results published in the journal Lung Cancer, sequential administration of chemotherapy including cisplatin (Platinol®) and gemcitabine (Gemzar®) followed by mitoxantrone (Novantrone®),... Continue Reading
Alimta® and Paraplatin® Effective and Well-Tolerated in Mesothelioma (March 22, 2006)Alimta® and Paraplatin® Effective and Well-Tolerated in Mesothelioma According to an article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Alimta® (pemetrexed) and Paraplatin® (carboplatin) is an effective... Continue Reading
Early Chemotherapy Improves Outcomes for Mesothelioma (February 9, 2006)Early Chemotherapy Improves Outcomes for Mesothelioma According to a recent article published in the Annals of Oncology, immediate treatment with chemotherapy improves survival rates at one year and provides improved quality of life compared to administering... Continue Reading
Osteopontin: Marker for Mesothelioma (October 13, 2005)Osteopontin: Marker for Mesothelioma According to a recent article published in the New England Journal of Medicine, the protein osteopontin, which can be found in circulating blood, may help in the early detection of mesothelioma. However, further... Continue Reading